Search

everythinglearnresearchcommunity

for

Search:↓

Targeting EGFR may help reduce hair loss from chemotherapy.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Basonuclin 2 is vital for the development of facial bones, hair follicles, and male germ cells in adult mice, and its absence can lead to dwarfism and abnormal follicles.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

Overexpressing ovine β-catenin in mice skin increases hair follicle density and growth.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

New treatment using Minoxidil and EGCG with ionic liquids improves hair growth and quality for hair loss.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The hairless gene mutation causes baldness by disrupting hair follicle structure.

IGF-I promotes hair growth by keeping hair follicles in the growth phase longer.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

PPARβ/δ helps yaks adapt to high altitudes by regulating lipid metabolism in their coats.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

FGF-7 helps hair grow by activating hair follicles and is a promising target for hair loss treatments.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Certain genes are linked to wool follicle structure and function, but not hair cycle regulation.

Rosmarinus officinalis tincture significantly improves hair volume and density.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.